<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02029755</url>
  </required_header>
  <id_info>
    <org_study_id>201309028</org_study_id>
    <nct_id>NCT02029755</nct_id>
  </id_info>
  <brief_title>Transversus Abdominis Plane Block Versus Local Anesthetic Infiltration for Pain Control in the Abdominal Surgery</brief_title>
  <acronym>TAP</acronym>
  <official_title>Ultrasound-guided-transversus Abdominis Plane(TAP) Block Versus Local Anesthetic(LA) Infiltration—the Effectiveness of Post-operative Pain Control in the Abdominal Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Taipei Medical University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Taipei Medical University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Postoperative analgesia is an important part of the anesthetic care. According to the recent
      studies, multimodal analgesia can provide better analgesia &amp; patient satisfaction with fewer
      side effect. For example, combining intravenous, intramuscular or oral analgesics with
      transversus abdominis plane (TAP) block or local anesthetic (LA) infiltration as the
      multimodal analgesia, can furnish a more effective pain control after the abdominal surgery.

      For abdominal surgery, both local infiltration and TAP block target on relieving somatic
      pain. Local anesthetic wound infiltration is easy to perform with low risk. As the
      advancement of ultrasound technology, performing the TAP block also becomes easier, safer and
      more accurate. But whether LA infiltration or TAP block is better for the multimodal
      analgesia regimen remains unclear.

      This study is to compare the postoperative pain score, opioid consumption, side effects, and
      quality of recovery between these two analgesic methods in patients undergoing abdominal
      surgery. The investigators hypothesized that TAP block may be more effective than LA
      infiltration as a part of the multimodal analgesia, and can improve the recovery after the
      abdominal surgery.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Actual">June 2014</completion_date>
  <primary_completion_date type="Actual">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Score (NRS: Numerical Rating Scale)</measure>
    <time_frame>postoperative 24 hour dynamic</time_frame>
    <description>pain scores of the participants will be followed at postoperative 1, 6, 24, 48 hour (up to 48 hours).
(NRS: from 0 to 10, 0 = no pain, 10 = the worst pain) The higher score idicates the worse outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Opioid Consumption</measure>
    <time_frame>postoperative 48 hour</time_frame>
    <description>opioid consumption of the participants will be followed at postoperative 1, 6, 12, 24, 36, 48 hour (up to 48 hours).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sedation Scale</measure>
    <time_frame>postoperative 1, 6, 24, 48 hour</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nausea and Vomiting Categorical Score</measure>
    <time_frame>postoperative 1, 6, 24, 48 hour</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rescue Analgesic Use</measure>
    <time_frame>postoperative 1, 6, 12, 24, 36, 48 hour</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rescue Antiemetics Use</measure>
    <time_frame>postoperative 1, 6, 12, 24, 36, 48 hour</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to the First Request of Analgesics</measure>
    <time_frame>an expected average of 5 days</time_frame>
    <description>participants will be followed for the duration of hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pruritus</measure>
    <time_frame>postoperative 1, 6, 24, 48 hour</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Recovery 40</measure>
    <time_frame>postoperative 48 hour</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Rate Variability</measure>
    <time_frame>preoperative, postoperative 1 hour and 1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Flatus</measure>
    <time_frame>an expected average of 5 days</time_frame>
    <description>participants will be followed for the duration of hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Hospital Stay</measure>
    <time_frame>an expected average of 5 days</time_frame>
    <description>participants will be followed for the duration of hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Intervention-related Complication</measure>
    <time_frame>an expected average of 5 days</time_frame>
    <description>participants will be followed for the duration of hospital stay</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">108</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>TAP block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>postoperative analgesia with sono-guided transversus abdominis plane block and intravenous patient controlled analgesia (IV-PCA). Bilateral sono-guided TAP block will be performed after the induction of general anesthesia. 20 ml of 0.25% ropivacaine will be injected to the transversus abdominis plane under ultrasound guidance at each side (total 40 ml). IV-PCA with morphine will be ready for postoperative pain control at the end of the surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Local infiltration</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>postoperative analgesia with local anesthetics infiltration at surgical wound and intravenous patient controlled analgesia (IV-PCA). 20 ml of 0.5% ropivacaine will be injected at the surgical wound by the surgeon before the closure of wound. IV-PCA with morphine will be ready for postoperative pain control at the end of the surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PCA only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>postoperative analgesia with intravenous patient controlled analgesia. IV-PCA with morphine will be ready for postoperative pain control at the end of the surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>transversus abdominis plane block</intervention_name>
    <description>bilateral ultrasound-guided transversus abdominis plane block, with 20 ml of 0.25% ropivacaine at each side after the induction of general anesthesia</description>
    <arm_group_label>TAP block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>local infiltration</intervention_name>
    <description>local anesthetics infiltration at surgical wound with 20 ml of 0.5% ropivacaine before wound closure</description>
    <arm_group_label>Local infiltration</arm_group_label>
    <other_name>local anesthetics infiltration</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Patient controlled analgesia</intervention_name>
    <description>postoperative analgesia with intravenous patient controlled analgesia with morphine</description>
    <arm_group_label>TAP block</arm_group_label>
    <arm_group_label>Local infiltration</arm_group_label>
    <arm_group_label>PCA only</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult (20~65y/o)

          -  American Society of Anesthesiologists (ASA) physical status I~II

          -  Patients scheduled for regular abdominal surgery under general anesthesia

        Exclusion Criteria:

          -  ASA physical status ≥ 3

          -  Allergy to morphine or local anesthetics

          -  Morphine tolerance

          -  Drug abuse or addiction

          -  Bleeding tendency
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chuen-Chau Chang, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Taipei Medical University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Taipei Medical University Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>110</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 5, 2014</study_first_submitted>
  <study_first_submitted_qc>January 7, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 8, 2014</study_first_posted>
  <results_first_submitted>November 21, 2014</results_first_submitted>
  <results_first_submitted_qc>May 24, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 8, 2015</results_first_posted>
  <last_update_submitted>May 24, 2015</last_update_submitted>
  <last_update_submitted_qc>May 24, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 8, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Taipei Medical University Hospital</investigator_affiliation>
    <investigator_full_name>hsiao chien tsai</investigator_full_name>
    <investigator_title>fellow researcher</investigator_title>
  </responsible_party>
  <keyword>transversus abdominis plane block</keyword>
  <keyword>local infiltration</keyword>
  <keyword>ropivacaine</keyword>
  <keyword>heart rate variability</keyword>
  <keyword>postoperative analgesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Anesthetics, Local</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>TAP Block</title>
          <description>postoperative analgesia with sono-guided transversus abdominis plane block and intravenous patient controlled analgesia (IV-PCA). Bilateral sono-guided TAP block will be performed after the induction of general anesthesia. 20 ml of 0.25% ropivacaine will be injected to the transversus abdominis plane under ultrasound guidance at each side (total 40 ml). IV-PCA with morphine will be ready for postoperative pain control at the end of the surgery.
transversus abdominis plane block: bilateral ultrasound-guided transversus abdominis plane block, with 20 ml of 0.25% ropivacaine at each side after the induction of general anesthesia
Patient controlled analgesia: postoperative analgesia with intravenous patient controlled analgesia with morphine</description>
        </group>
        <group group_id="P2">
          <title>Local Infiltration</title>
          <description>postoperative analgesia with local anesthetics infiltration at surgical wound and intravenous patient controlled analgesia (IV-PCA). 20 ml of 0.5% ropivacaine will be injected at the surgical wound by the surgeon before the closure of wound. IV-PCA with morphine will be ready for postoperative pain control at the end of the surgery.
local infiltration: local anesthetics infiltration at surgical wound with 20 ml of 0.5% ropivacaine before wound closure
Patient controlled analgesia: postoperative analgesia with intravenous patient controlled analgesia with morphine</description>
        </group>
        <group group_id="P3">
          <title>PCA Only</title>
          <description>postoperative analgesia with intravenous patient controlled analgesia. IV-PCA with morphine will be ready for postoperative pain control at the end of the surgery.
Patient controlled analgesia: postoperative analgesia with intravenous patient controlled analgesia with morphine</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="36"/>
                <participants group_id="P2" count="36"/>
                <participants group_id="P3" count="36"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="36"/>
                <participants group_id="P2" count="36"/>
                <participants group_id="P3" count="36"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>TAP Block</title>
          <description>postoperative analgesia with sono-guided transversus abdominis plane block and intravenous patient controlled analgesia (IV-PCA). Bilateral sono-guided TAP block will be performed after the induction of general anesthesia. 20 ml of 0.25% ropivacaine will be injected to the transversus abdominis plane under ultrasound guidance at each side (total 40 ml). IV-PCA with morphine will be ready for postoperative pain control at the end of the surgery.
transversus abdominis plane block: bilateral ultrasound-guided transversus abdominis plane block, with 20 ml of 0.25% ropivacaine at each side after the induction of general anesthesia
Patient controlled analgesia: postoperative analgesia with intravenous patient controlled analgesia with morphine</description>
        </group>
        <group group_id="B2">
          <title>Local Infiltration</title>
          <description>postoperative analgesia with local anesthetics infiltration at surgical wound and intravenous patient controlled analgesia (IV-PCA). 20 ml of 0.5% ropivacaine will be injected at the surgical wound by the surgeon before the closure of wound. IV-PCA with morphine will be ready for postoperative pain control at the end of the surgery.
local infiltration: local anesthetics infiltration at surgical wound with 20 ml of 0.5% ropivacaine before wound closure
Patient controlled analgesia: postoperative analgesia with intravenous patient controlled analgesia with morphine</description>
        </group>
        <group group_id="B3">
          <title>PCA Only</title>
          <description>postoperative analgesia with intravenous patient controlled analgesia. IV-PCA with morphine will be ready for postoperative pain control at the end of the surgery.
Patient controlled analgesia: postoperative analgesia with intravenous patient controlled analgesia with morphine</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="36"/>
            <count group_id="B2" value="36"/>
            <count group_id="B3" value="36"/>
            <count group_id="B4" value="108"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40.17" spread="7.28"/>
                    <measurement group_id="B2" value="39.69" spread="5.38"/>
                    <measurement group_id="B3" value="42.69" spread="6.93"/>
                    <measurement group_id="B4" value="40.85" spread="6.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                    <measurement group_id="B2" value="36"/>
                    <measurement group_id="B3" value="36"/>
                    <measurement group_id="B4" value="108"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                    <measurement group_id="B2" value="36"/>
                    <measurement group_id="B3" value="36"/>
                    <measurement group_id="B4" value="108"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or Other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than one race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Taiwan</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                    <measurement group_id="B2" value="36"/>
                    <measurement group_id="B3" value="36"/>
                    <measurement group_id="B4" value="108"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Pain Score (NRS: Numerical Rating Scale)</title>
        <description>pain scores of the participants will be followed at postoperative 1, 6, 24, 48 hour (up to 48 hours).
(NRS: from 0 to 10, 0 = no pain, 10 = the worst pain) The higher score idicates the worse outcome.</description>
        <time_frame>postoperative 24 hour dynamic</time_frame>
        <group_list>
          <group group_id="O1">
            <title>TAP Block</title>
            <description>postoperative analgesia with sono-guided transversus abdominis plane block and intravenous patient controlled analgesia (IV-PCA). Bilateral sono-guided TAP block will be performed after the induction of general anesthesia. 20 ml of 0.25% ropivacaine will be injected to the transversus abdominis plane under ultrasound guidance at each side (total 40 ml). IV-PCA with morphine will be ready for postoperative pain control at the end of the surgery.
transversus abdominis plane block: bilateral ultrasound-guided transversus abdominis plane block, with 20 ml of 0.25% ropivacaine at each side after the induction of general anesthesia
Patient controlled analgesia: postoperative analgesia with intravenous patient controlled analgesia with morphine</description>
          </group>
          <group group_id="O2">
            <title>Local Infiltration</title>
            <description>postoperative analgesia with local anesthetics infiltration at surgical wound and intravenous patient controlled analgesia (IV-PCA). 20 ml of 0.5% ropivacaine will be injected at the surgical wound by the surgeon before the closure of wound. IV-PCA with morphine will be ready for postoperative pain control at the end of the surgery.
local infiltration: local anesthetics infiltration at surgical wound with 20 ml of 0.5% ropivacaine before wound closure
Patient controlled analgesia: postoperative analgesia with intravenous patient controlled analgesia with morphine</description>
          </group>
          <group group_id="O3">
            <title>PCA Only</title>
            <description>postoperative analgesia with intravenous patient controlled analgesia. IV-PCA with morphine will be ready for postoperative pain control at the end of the surgery.
Patient controlled analgesia: postoperative analgesia with intravenous patient controlled analgesia with morphine</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Score (NRS: Numerical Rating Scale)</title>
          <description>pain scores of the participants will be followed at postoperative 1, 6, 24, 48 hour (up to 48 hours).
(NRS: from 0 to 10, 0 = no pain, 10 = the worst pain) The higher score idicates the worse outcome.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
                <count group_id="O2" value="36"/>
                <count group_id="O3" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.50" spread="1.98"/>
                    <measurement group_id="O2" value="4.81" spread="1.77"/>
                    <measurement group_id="O3" value="4.17" spread="1.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Opioid Consumption</title>
        <description>opioid consumption of the participants will be followed at postoperative 1, 6, 12, 24, 36, 48 hour (up to 48 hours).</description>
        <time_frame>postoperative 48 hour</time_frame>
        <group_list>
          <group group_id="O1">
            <title>TAP Block</title>
            <description>postoperative analgesia with sono-guided transversus abdominis plane block and intravenous patient controlled analgesia (IV-PCA). Bilateral sono-guided TAP block will be performed after the induction of general anesthesia. 20 ml of 0.25% ropivacaine will be injected to the transversus abdominis plane under ultrasound guidance at each side (total 40 ml). IV-PCA with morphine will be ready for postoperative pain control at the end of the surgery.
transversus abdominis plane block: bilateral ultrasound-guided transversus abdominis plane block, with 20 ml of 0.25% ropivacaine at each side after the induction of general anesthesia
Patient controlled analgesia: postoperative analgesia with intravenous patient controlled analgesia with morphine</description>
          </group>
          <group group_id="O2">
            <title>Local Infiltration</title>
            <description>postoperative analgesia with local anesthetics infiltration at surgical wound and intravenous patient controlled analgesia (IV-PCA). 20 ml of 0.5% ropivacaine will be injected at the surgical wound by the surgeon before the closure of wound. IV-PCA with morphine will be ready for postoperative pain control at the end of the surgery.
local infiltration: local anesthetics infiltration at surgical wound with 20 ml of 0.5% ropivacaine before wound closure
Patient controlled analgesia: postoperative analgesia with intravenous patient controlled analgesia with morphine</description>
          </group>
          <group group_id="O3">
            <title>PCA Only</title>
            <description>postoperative analgesia with intravenous patient controlled analgesia. IV-PCA with morphine will be ready for postoperative pain control at the end of the surgery.
Patient controlled analgesia: postoperative analgesia with intravenous patient controlled analgesia with morphine</description>
          </group>
        </group_list>
        <measure>
          <title>Opioid Consumption</title>
          <description>opioid consumption of the participants will be followed at postoperative 1, 6, 12, 24, 36, 48 hour (up to 48 hours).</description>
          <units>mg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
                <count group_id="O2" value="36"/>
                <count group_id="O3" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.69" spread="19.20"/>
                    <measurement group_id="O2" value="28.33" spread="15.89"/>
                    <measurement group_id="O3" value="21.53" spread="16.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sedation Scale</title>
        <time_frame>postoperative 1, 6, 24, 48 hour</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Nausea and Vomiting Categorical Score</title>
        <time_frame>postoperative 1, 6, 24, 48 hour</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Rescue Analgesic Use</title>
        <time_frame>postoperative 1, 6, 12, 24, 36, 48 hour</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Rescue Antiemetics Use</title>
        <time_frame>postoperative 1, 6, 12, 24, 36, 48 hour</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to the First Request of Analgesics</title>
        <description>participants will be followed for the duration of hospital stay</description>
        <time_frame>an expected average of 5 days</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pruritus</title>
        <time_frame>postoperative 1, 6, 24, 48 hour</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Quality of Recovery 40</title>
        <time_frame>postoperative 48 hour</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Heart Rate Variability</title>
        <time_frame>preoperative, postoperative 1 hour and 1 day</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Flatus</title>
        <description>participants will be followed for the duration of hospital stay</description>
        <time_frame>an expected average of 5 days</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of Hospital Stay</title>
        <description>participants will be followed for the duration of hospital stay</description>
        <time_frame>an expected average of 5 days</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Intervention-related Complication</title>
        <description>participants will be followed for the duration of hospital stay</description>
        <time_frame>an expected average of 5 days</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>TAP Block</title>
          <description>postoperative analgesia with sono-guided transversus abdominis plane block and intravenous patient controlled analgesia (IV-PCA). Bilateral sono-guided TAP block will be performed after the induction of general anesthesia. 20 ml of 0.25% ropivacaine will be injected to the transversus abdominis plane under ultrasound guidance at each side (total 40 ml). IV-PCA with morphine will be ready for postoperative pain control at the end of the surgery.
transversus abdominis plane block: bilateral ultrasound-guided transversus abdominis plane block, with 20 ml of 0.25% ropivacaine at each side after the induction of general anesthesia
Patient controlled analgesia: postoperative analgesia with intravenous patient controlled analgesia with morphine</description>
        </group>
        <group group_id="E2">
          <title>Local Infiltration</title>
          <description>postoperative analgesia with local anesthetics infiltration at surgical wound and intravenous patient controlled analgesia (IV-PCA). 20 ml of 0.5% ropivacaine will be injected at the surgical wound by the surgeon before the closure of wound. IV-PCA with morphine will be ready for postoperative pain control at the end of the surgery.
local infiltration: local anesthetics infiltration at surgical wound with 20 ml of 0.5% ropivacaine before wound closure
Patient controlled analgesia: postoperative analgesia with intravenous patient controlled analgesia with morphine</description>
        </group>
        <group group_id="E3">
          <title>PCA Only</title>
          <description>postoperative analgesia with intravenous patient controlled analgesia. IV-PCA with morphine will be ready for postoperative pain control at the end of the surgery.
Patient controlled analgesia: postoperative analgesia with intravenous patient controlled analgesia with morphine</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="36"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="36"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="36"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="36"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="36"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="36"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Hsiao-Chien Tsai</name_or_title>
      <organization>Taipei medical university hospital</organization>
      <phone>+886-2-27372181 ext 8310</phone>
      <email>hctsai.anes@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

